{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T03:40:22Z","timestamp":1739763622493,"version":"3.37.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T00:00:00Z","timestamp":1265068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11033-010-9979-3","type":"journal-article","created":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T07:21:19Z","timestamp":1265008879000},"page":"3101-3105","source":"Crossref","is-referenced-by-count":2,"title":["Quantitative detection of BCR\u2013ABL fusion gene and its application in monitoring chronic myeloid leukemia treatment"],"prefix":"10.1007","volume":"38","author":[{"given":"Xiaojun","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingbo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanxin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binwu","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanlan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,2]]},"reference":[{"issue":"1","key":"9979_CR1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-4608(96)00292-0","volume":"94","author":"GW Dewald","year":"1997","unstructured":"Dewald GW, Juneau AL, Schad CR et al (1997) Cytogenetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia. Cancer Genet Cytogenet 94(1):59\u201366","journal-title":"Cancer Genet Cytogenet"},{"issue":"24 Suppl 15","key":"9979_CR2","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.2146\/ajhp070482","volume":"64","author":"C Fausel","year":"2007","unstructured":"Fausel C (2007) Targeted chronic myeloid leukemia therapy: seeking a cure. Am J Health Syst Pharm 64(24 Suppl 15):S9\u2013S15","journal-title":"Am J Health Syst Pharm"},{"unstructured":"Guido M, Danilo P, Michael A (2003) Understanding the molecular basis of Imatinib mesylate therapy in chronic myelogenous leukemia and the related mechanisms of resistance. Clin Cancer Res 9:1248\u20131252","key":"9979_CR3"},{"issue":"2","key":"9979_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2353\/jmoldx.2006.040404","volume":"8","author":"YL Wang","year":"2006","unstructured":"Wang YL, Joong WL, Ethel C et al (2006) Molecular monitoring of chronic myelogenous leukemia. J Mol Diagn 8(2):231\u2013239","journal-title":"J Mol Diagn"},{"issue":"12","key":"9979_CR5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00277-002-0547-3","volume":"81","author":"M Carrasco","year":"2002","unstructured":"Carrasco M, Sureda A, Martinez C et al (2002) Prognostic factors influencing feasibility of cytogenetic and molecular analysis in leukapheresis products in chronic myelogenous leukemia patients. Ann Hematol 81(12):710\u2013716","journal-title":"Ann Hematol"},{"issue":"1","key":"9979_CR6","first-page":"27","volume":"108","author":"H Timothy","year":"2006","unstructured":"Timothy H, Michael D, Andreas H et al (2006) Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood 108(1):27\u201337","journal-title":"Blood"},{"key":"9979_CR7","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","volume":"17","author":"E Beillard","year":"2003","unstructured":"Beillard E, Pallisgaard N, van der Velden VH et al (2003) Evaluation of candidate control genes for diagnosis and residual disease detection in leukemia patients using \u201creal-time\u201d quantitative reverse transcriptase polymerase chain reaction (RQ-PCR)\u2014a Europe against cancer program. Leukemia 17:2474\u20132486","journal-title":"Leukemia"},{"key":"9979_CR8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1006\/bcmd.1997.0155","volume":"23","author":"C Gambacotti-Passerini","year":"1997","unstructured":"Gambacotti-Passerini C, le Coutre P, Mologni L et al (1997) Inhibition of the ABL kinase activity blocks the proliferation of BCR-ABL\u00a0+\u00a0leukemia cells and induces apoptosis. Blood Cell Mol Dis 23:380\u2013394","journal-title":"Blood Cell Mol Dis"},{"key":"9979_CR9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(24)38879-2","volume":"295","author":"E Buchdunger","year":"2000","unstructured":"Buchdunger E, Cioffi CL, Law N et al (2000) A protein-tyrosine kinase inhibitor ST1571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Phamacol Exp Ther 295:139\u2013145","journal-title":"J Phamacol Exp Ther"},{"key":"9979_CR10","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1182\/blood.V99.6.1928","volume":"99","author":"M Talpaz","year":"2002","unstructured":"Talpaz M, Richard T, Silver B et al (2002) Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study. Blood 99:1928\u20131937","journal-title":"Blood"},{"key":"9979_CR11","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1182\/blood-2002-12-3659","volume":"101","author":"AS Corbin","year":"2003","unstructured":"Corbin AS, La Rosee P, Stoffregen EP et al (2003) Several Bcr\u2013Abl kinase domain mutants associated with Imatinib mesylate resistance remain sensitive to Imatinib. Blood 101:4611\u20134614","journal-title":"Blood"},{"issue":"9","key":"9979_CR12","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1158\/1078-0432.CCR-04-2139","volume":"11","author":"C Jorge","year":"2005","unstructured":"Jorge C, Moshe T, Susan OB (2005) Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with Imatinib mesylate. Clin Cancer Res 11(9):3425\u20133432","journal-title":"Clin Cancer Res"},{"key":"9979_CR13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0140-6736(93)92619-5","volume":"341","author":"T Lion","year":"1993","unstructured":"Lion T, Gaiger A et al (1993) Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia. Lancet 341:275","journal-title":"Lancet"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-010-9979-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-010-9979-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-010-9979-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T03:27:50Z","timestamp":1739762870000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-010-9979-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,2]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["9979"],"URL":"https:\/\/doi.org\/10.1007\/s11033-010-9979-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2010,2,2]]}}}